TONICIP

This brand name is authorized in Nigeria.

Active ingredients

The drug TONICIP contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 5E8K9I0O4U - CIPROFLOXACIN
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-8124	Solution for infusion	Tonicip Infusion_ INJ_SOL 200 mg/100 mL 100 mL (in FFS plastic bottle)	Clear Colourless Solution 92 TONICIP INFUSION TONICIP CIPROFLOXACIN CIPROFLOXACIN 200MG/100ML PRESCRIPTION ONLY MEDICINE INFUSION 1 X 100ML ANTIBIOTIC VALUELIFE PHARMA CO. LTD., NO. 46, IFITE ROAD, OFF HIGH TENSION STREET, ARROMA, AWKA, ANAMBRA STATE EUROLIFE HEALTHCARE PVT LTD UNIT II, KHASRA NO: 520, VILLAGE BHAGWANPUR ROORKEE, DIST-HARIDWAR (UTTARAKHAND) INDIA B4-8124 TREATMENT OF INFECTIONS CAUSED BY SUSCEPTIBLE ORGANISMS 08/26/2021 08/25/2026	26/08/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-8124